Medicine

Adalimumab in Granuloma Annulare

Spain· Universitat de Lleida· January 2026
About this call

Objectives: To systematically review and synthesize the available evidence on clinical response, treatment regimens, relapse, and adverse events associated with adalimumab in granuloma annulare.


GE
Guillem Esteve Boncompte
Universitat de Lleida

You need an account to apply. Sign up free or sign in.